NOVAVAX INC (NVAX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 700M 1.4B 2.1B Q3 '16: 15.8M Q4 '16: 15.4M Q1 '17: 16.8M Q2 '17: 21M Q3 '17: 26.2M Q4 '17: 31.2M Q1 '18: 35.1M Q2 '18: 39.2M Q3 '18: 38.6M Q4 '18: 34.3M Q1 '19: 28.6M Q2 '19: 21.2M Q3 '19: 16M Q4 '19: 18.7M Q1 '20: 18.1M Q2 '20: 50.2M Q3 '20: 204.8M Q4 '20: 475.6M Q1 '21: 919.5M Q2 '21: 1.2B Q3 '21: 1.2B Q4 '21: 1.1B Q1 '22: 1.4B Q2 '22: 1.3B Q3 '22: 1.8B Q4 '22: 2B Q1 '23: 1.4B Q2 '23: 1.6B Q3 '23: 1B Q4 '23: 983.7M Q1 '24: 996.6M Q2 '24: 987.7M Q3 '24: 885.2M Q4 '24: 682.2M Q1 '25: 1.3B Q2 '25: 1.1B Q3 '25: 1.1B Q4 '25: 1.1B Q1 '26: 596.3M Q2 '26: 413.8M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit TTM

0 500M 1B 1.5B Q4 '21: 1.1B Q1 '22: 1.4B Q2 '22: 1B Q3 '22: 1.1B Q4 '22: 1.1B Q1 '23: 437.3M Q2 '23: 891.1M Q3 '23: 679.2M Q4 '23: 639.9M Q1 '24: 627.7M Q2 '24: 628.3M Q3 '24: 564.1M Q4 '24: 479.4M Q1 '25: 1.1B Q2 '25: 952M Q3 '25: 977M Q4 '25: 1.1B Q1 '26: 506.7M Q2 '26: 325.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income TTM

-1.8B -1.2B -600M 0 600M 1.2B 1.8B Q3 '16: -294M Q4 '16: -269.1M Q1 '17: -234.7M Q2 '17: -199.7M Q3 '17: -178M Q4 '17: -171.7M Q1 '18: -174.4M Q2 '18: -174.9M Q3 '18: -175.2M Q4 '18: -173.9M Q1 '19: -170.6M Q2 '19: -165.3M Q3 '19: -138.4M Q4 '19: -120.6M Q1 '20: -103.3M Q2 '20: -83.6M Q3 '20: -262.6M Q4 '20: -416.7M Q1 '21: -602.5M Q2 '21: -931.3M Q3 '21: -1B Q4 '21: -1.7B Q1 '22: -1.3B Q2 '22: -1.4B Q3 '22: -1.2B Q4 '22: -644.7M Q1 '23: -1.2B Q2 '23: -628.4M Q3 '23: -626.8M Q4 '23: -566.5M Q1 '24: -398.6M Q2 '24: -293M Q3 '24: -301.4M Q4 '24: -248.9M Q1 '25: 411.4M Q2 '25: 351.5M Q3 '25: 307.5M Q4 '25: 452.8M Q1 '26: -78.1M Q2 '26: -234.1M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Net Income TTM

-1.8B -1.2B -600M 0 600M 1.2B 1.8B Q3 '16: -301.7M Q4 '16: -280M Q1 '17: -246.6M Q2 '17: -211.7M Q3 '17: -190M Q4 '17: -183.8M Q1 '18: -186.3M Q2 '18: -186.3M Q3 '18: -186.3M Q4 '18: -184.7M Q1 '19: -181.6M Q2 '19: -176.7M Q3 '19: -150.2M Q4 '19: -132.7M Q1 '20: -115.3M Q2 '20: -93.3M Q3 '20: -272.5M Q4 '20: -418.3M Q1 '21: -615.1M Q2 '21: -949.9M Q3 '21: -1.1B Q4 '21: -1.7B Q1 '22: -1.3B Q2 '22: -1.5B Q3 '22: -1.3B Q4 '22: -657.9M Q1 '23: -1.2B Q2 '23: -586.8M Q3 '23: -548.9M Q4 '23: -545.1M Q1 '24: -398.7M Q2 '24: -294.3M Q3 '24: -284.9M Q4 '24: -187.5M Q1 '25: 478.7M Q2 '25: 422.8M Q3 '25: 341.7M Q4 '25: 440.3M Q1 '26: -87.8M Q2 '26: -247.7M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue TTM

0 350M 700M 1.1B Q4 '21: 0 Q1 '22: 15.2M Q2 '22: 286.3M Q3 '22: 720.9M Q4 '22: 902.6M Q1 '23: 921.5M Q2 '23: 706.2M Q3 '23: 370.6M Q4 '23: 343.8M Q1 '24: 368.9M Q2 '24: 359.4M Q3 '24: 321M Q4 '24: 202.7M Q1 '25: 157.6M Q2 '25: 126.7M Q3 '25: 87.6M Q4 '25: 73M Q1 '26: 89.6M Q2 '26: 88.5M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

-900M -600M -300M 0 300M 600M 900M Q3 '15: -91.1M Q4 '15: -126.1M Q1 '16: -165.4M Q2 '16: -215.1M Q3 '16: -249M Q4 '16: -258.8M Q1 '17: -233.4M Q2 '17: -183.8M Q3 '17: -165.6M Q4 '17: -144.5M Q1 '18: -166.1M Q2 '18: -193.6M Q3 '18: -183M Q4 '18: -184.8M Q1 '19: -169.4M Q2 '19: -159.4M Q3 '19: -158.1M Q4 '19: -136.6M Q1 '20: -109.1M Q2 '20: 36.5M Q3 '20: 62.3M Q4 '21: 322.9M Q1 '22: -428.6M Q2 '22: -744M Q3 '22: -640.5M Q4 '22: -415.9M Q1 '23: -653M Q2 '23: -654.1M Q3 '23: -655M Q4 '23: -714M Q1 '24: -471.9M Q2 '24: 14.3M Q3 '24: -90.9M Q4 '24: -87.3M Q1 '25: -189.2M Q2 '25: -630.9M Q3 '25: -378.3M Q4 '25: -244.6M Q1 '26: -91.6M Q2 '26: -36.9M Q3 '16 Q4 '17 Q1 '19 Q2 '20 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Free Cash Flow TTM

-900M -600M -300M 0 300M 600M 900M Q3 '11: -27.1M Q4 '11: -24.2M Q1 '12: -20.1M Q2 '12: -18M Q3 '12: -20.2M Q4 '12: -22.6M Q1 '13: -29.7M Q2 '13: -32.5M Q3 '13: -43.2M Q4 '13: -51.1M Q1 '14: -60.3M Q2 '14: -63M Q3 '14: -65.4M Q4 '14: -74.3M Q1 '15: -88.3M Q2 '15: -93.1M Q3 '15: -107.1M Q4 '15: -144.4M Q1 '16: -184.4M Q2 '16: -235.2M Q3 '16: -268.6M Q4 '16: -277M Q1 '17: -247.2M Q2 '17: -193.3M Q3 '17: -172.4M Q4 '17: -148.7M Q1 '18: -169.3M Q2 '18: -196M Q3 '18: -184.5M Q4 '18: -186.2M Q1 '19: -171.4M Q2 '19: -161.6M Q3 '19: -160.3M Q4 '19: -138.5M Q1 '20: -110.3M Q2 '20: 32.1M Q3 '20: 49.5M Q4 '21: 265.5M Q1 '22: -489.2M Q2 '22: -813.9M Q3 '12 Q4 '13 Q1 '15 Q2 '16 Q3 '17 Q4 '18 Q1 '20 Q2 '22

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 70M 140M 210M Q2 '20: 58.6M Q3 '20: 61.6M Q1 '21: 73M Q2 '21: 74.1M Q3 '21: 74.7M Q1 '22: 80.7M Q2 '22: 78.1M Q3 '22: 78.3M Q1 '23: 86.2M Q2 '23: 104.1M Q3 '23: 103.4M Q1 '24: 139.9M Q2 '24: 165.9M Q3 '24: 160M Q1 '25: 177.6M Q2 '25: 177.2M Q3 '25: 162.4M Q1 '26: 163.3M Q2 '26: 164.6M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-24.00 -16.00 -8.00 0.00 8.00 16.00 24.00 Q3 '16: -1.11 Q4 '16: -1.03 Q1 '17: -0.90 Q2 '17: -0.77 Q3 '17: -0.68 Q4 '17: -0.63 Q1 '18: -0.61 Q2 '18: -2.82 Q3 '18: -5.00 Q4 '18: -7.41 Q1 '19: -9.38 Q2 '19: -8.70 Q3 '19: -7.11 Q4 '19: -5.67 Q1 '20: -4.14 Q2 '20: -2.75 Q3 '20: -5.22 Q4 '20: -6.97 Q1 '21: -9.44 Q2 '21: -13.89 Q3 '21: -14.99 Q4 '21: -23.42 Q1 '22: -17.81 Q2 '22: -19.59 Q3 '22: -17.43 Q4 '22: -8.41 Q1 '23: -14.38 Q2 '23: -7.27 Q3 '23: -6.38 Q4 '23: -5.56 Q1 '24: -3.20 Q2 '24: -2.79 Q3 '24: -2.29 Q4 '24: -1.34 Q1 '25: 2.64 Q2 '25: 2.27 Q3 '25: 1.78 Q4 '25: 2.58 Q1 '26: -0.41 Q2 '26: -1.35 Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.